These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3993535)

  • 21. Cardiac and pulmonary effects of acebutolol.
    Kumana CR; Kaye CM; Leighton M; Turner P; Hamer J
    Lancet; 1975 Jul; 2(7925):89-93. PubMed ID: 49736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
    Kubac G; Klinke WP; Grace M
    Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease.
    de Soyza N; Kane JJ; Murphy ML; Laddu AR; Doherty JE; Bissett JK
    Am Heart J; 1980 Nov; 100(5):631-8. PubMed ID: 6778183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of premature ventricular complexes with acebutolol.
    Aronow WS; Turbow M; Lurie M; Whittaker K; Van Camp S
    Am J Cardiol; 1979 Jan; 43(1):106-8. PubMed ID: 758758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
    Anderson JL
    Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
    Abengowe CU
    J Int Med Res; 1985; 13(2):116-21. PubMed ID: 2860041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris.
    Miller NE; Nanjee MN; Rajput-Williams J; Coltart DJ
    Am Heart J; 1987 Oct; 114(4 Pt 2):1007-10. PubMed ID: 3310569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine.
    Winkle RA; Gradman AH; Fitzgerald JW
    Am J Cardiol; 1978 Sep; 42(3):473-80. PubMed ID: 685858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acebutolol and propranolol on left ventricular performance assessed by echocardiography.
    Chandraratna PA; Aronow WS; Laddu A
    Clin Pharmacol Ther; 1980 Apr; 27(4):460-3. PubMed ID: 7357803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of antiarrhythmic agents on early-cycle premature ventricular complexes.
    Krone RJ; Miller JP; Kleiger RE; Clark KW; Oliver GC
    Circulation; 1981 Mar; 63(3):664-9. PubMed ID: 7006853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients.
    Birnbaum J; DiBianco R; Becker KL; Muesing R; Costello RB; Singh SN; Gottdiener JS; Fletcher RD
    Clin Pharmacol Ther; 1983 Mar; 33(3):294-300. PubMed ID: 6337762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of premature ventricular contractions by acebutolol.
    Gradman AH; Winkle RA; Fitzgerald JW; Meffin PJ; Stoner J; Bell PA; Harrison DC
    Circulation; 1977 May; 55(5):785-91. PubMed ID: 66105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison.
    Turner AS; Brocklehurst JC; Napier RN
    Am Heart J; 1985 May; 109(5 Pt 2):1178-83. PubMed ID: 3993534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined treatment with quinidine-propranolol for arrhythmia].
    Hardell LI; Warmenius S
    Lakartidningen; 1969 Sep; 66(38):3827-32. PubMed ID: 5384292
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of tocainide and quinidine on premature ventricular contractions.
    Wasenmiller JE; Aronow WS
    Clin Pharmacol Ther; 1980 Oct; 28(4):431-5. PubMed ID: 6773715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.